Research Domain Director, Cancer
Robert Bristow MD PhD FRCPC was appointed as Research Domain Director for Cancer in June 2018.
In addition to this role, he is also Director of the Manchester Cancer Research Centre, University Professor of Cancer Studies in the Division of Cancer Sciences and Chief Academic Officer at The Christie NHS Foundation Trust.
His research group, Translational Oncogenomics, sits within the Cancer Research UK Manchester Institute, where he is a Senior Group Leader.
He came to Manchester in 2017 from Toronto, Canada, where he was a Clinician-Scientist and Professor within the Departments of Radiation Oncology and Medical Biophysics at the University of Toronto.
As a Senior Scientist at the Princess Margaret Cancer Centre he treated genitourinary cancers. Rob is twice a Canadian Foundation for Innovation (CFI) awardee. He was made a Canadian Cancer Society Research Scientist in 2004 and an ESTRO Honorary Fellow in 2011.
His primary research interests are in tumour hypoxia, DNA damage signalling and DNA repair in tumours, and the genomics of prostate cancer progression and cancer treatment response.
He is particularly interested in novel clinical trials that intensify cancer therapy to prostate cancer patients whose tumours harbour aggressive genetic changes and hypoxic sub-regions.